The bioavailability and distribution of trans-resveratrol are constrained by ABC transporters

被引:107
|
作者
Planas, Joana M. [1 ,2 ]
Alfaras, Irene [1 ,2 ]
Colom, Helena [3 ]
Emilia Juan, M. [1 ,2 ]
机构
[1] Univ Barcelona, Dept Fisiol, E-08028 Barcelona, Spain
[2] Univ Barcelona, Inst Recerca Nutr & Seguretat Alimentaria INSA UB, E-08028 Barcelona, Spain
[3] Univ Barcelona, Fac Farm, Dept Farm Tecnol & Farmaceut, E-08028 Barcelona, Spain
关键词
Resveratrol; Oral bioavailability; Intestinal absorption; ATP binding cassette (ABC) transporters; Nutraceutical; CANCER RESISTANCE PROTEIN; INTESTINAL CACO-2 CELLS; MULTIDRUG-RESISTANCE; DRUG TRANSPORTERS; P-GLYCOPROTEIN; TISSUE DISTRIBUTION; MOUSE INTESTINE; RAT-LIVER; IN-VITRO; METABOLISM;
D O I
10.1016/j.abb.2012.06.004
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The ABC proteins are a family of membrane transporters that mediates the extrusion from cells of a wide variety of structurally unrelated substrates. The current review focuses on the role of these efflux pumps located in the intestine on the low oral bioavailability of trans-resveratrol. The enterocytes hold in the apical membrane three transporters, namely, P-glycoprotein (P-gp), multidnig resistance associated protein 2 (MRP2) and breast cancer resistance protein (BCRP), whereas the basolateral membrane contains multidrug resistance associated protein 3 (MRP3). The use of different specific inhibitors of these transporters as well as knockout mice enabled us to conclude that MRP2 and BCRP are involved in the extrusion of trans-resveratrol glucuronide and sulfate to the intestinal lumen without the participation of P-gp. The role of these transporters as a bottleneck in the absorption of trans-resveratrol cannot be undervalued affecting not only the bioavailability of its glucuronide and sulfate but also their distribution in the different organs. (C) 2012 Elsevier Inc. All rights reserved.
引用
收藏
页码:67 / 73
页数:7
相关论文
共 50 条
  • [1] Metabolism and bioavailability of trans-resveratrol
    Wenzel, E
    Somoza, V
    MOLECULAR NUTRITION & FOOD RESEARCH, 2005, 49 (05) : 472 - 481
  • [2] Optimization of trans-Resveratrol bioavailability for human therapy
    Amiot, Marie Josephe
    Romier, Beatrice
    Thi-Mai Anh Dao
    Fanciullino, Raphaelle
    Ciccolini, Joseph
    Burcelin, Remy
    Pechere, Laurent
    Emond, Claude
    Savouret, Jean-Francois
    Seree, Eric
    BIOCHIMIE, 2013, 95 (06) : 1233 - 1238
  • [3] USE OF NANOPARTICLES TO INCREASE THE SYSTEMIC BIOAVAILABILITY OF TRANS-RESVERATROL
    Oganesyan, E. A.
    Miroshnichenko, I. I.
    Vikhrieva, N. S.
    Lyashenko, A. A.
    Leshkov, S. Yu.
    PHARMACEUTICAL CHEMISTRY JOURNAL, 2010, 44 (02) : 74 - 76
  • [4] Use of nanoparticles to increase the systemic bioavailability of trans-resveratrol
    E. A. Oganesyan
    I. I. Miroshnichenko
    N. S. Vikhrieva
    A. A. Lyashenko
    S. Yu. Leshkov
    Pharmaceutical Chemistry Journal, 2010, 44 : 74 - 76
  • [5] Bioavailability of trans-resveratrol from red wine in humans
    Vitaglione, P
    Sforza, S
    Galaverna, G
    Ghidini, C
    Caporaso, N
    Vescovi, PP
    Fogliano, V
    Marchelli, R
    MOLECULAR NUTRITION & FOOD RESEARCH, 2005, 49 (05) : 495 - 504
  • [6] Biocompatible and biodegradable nanoparticles for enhancing solubility and bioavailability of trans-resveratrol
    Hu, Qiaobin
    Zhou, Fang
    Wang, Shu
    FASEB JOURNAL, 2022, 36
  • [7] Preformulation Stability of trans-Resveratrol and trans-Resveratrol Glucoside (Piceid)
    Jensen, James S.
    Wertz, Christian F.
    O'Neill, Victoria A.
    JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY, 2010, 58 (03) : 1685 - 1690
  • [8] trans-Resveratrol as A Neuroprotectant
    Robb, Ellen L.
    Stuart, Jeffrey A.
    MOLECULES, 2010, 15 (03): : 1196 - 1212
  • [9] Trans-Resveratrol Oral Bioavailability in Humans Using LipiSperse™ Dispersion Technology
    Briskey, David
    Rao, Amanda
    PHARMACEUTICS, 2020, 12 (12) : 1 - 11
  • [10] A practical synthesis of trans-resveratrol
    Shen, ZL
    Zhuo, GL
    Jiang, XZ
    INDIAN JOURNAL OF CHEMISTRY SECTION B-ORGANIC CHEMISTRY INCLUDING MEDICINAL CHEMISTRY, 2002, 41 (11): : 2395 - 2398